Evidence map›Paper›PMID 40370554›Full record

ArticleActa pharmaceutica Sinica. B2025

Parkin inhibits iron overload-induced cardiomyocyte ferroptosis by ubiquitinating ACSL4 and modulating PUFA-phospholipids metabolism.

Dandan Xiao, Wenguang Chang, Xiang Ao, Lin Ye, Weiwei Wu, Lin Song, Xiaosu Yuan, Luxin Feng, Peiyan Wang, Yu Wang and 3 more

Abstract read
In one paragraph

Article in Acta pharmaceutica Sinica. B, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Recent progress in understanding ferroptosis mechanisms in infectious diseases.Frontiers in cellular and infection microbiology · 2026
    Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Dandan XiaoInstitute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266021, China.
Wenguang ChangInstitute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266021, China.
Xiang AoInstitute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266021, China.
Lin YeInstitute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266021, China.
Weiwei WuSchool of Basic Medicine, Qingdao University, Qingdao 266071, China.
Lin SongSchool of Basic Medicine, Qingdao University, Qingdao 266071, China.
Xiaosu YuanInstitute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266021, China.
Luxin FengDepartment of Cardiovascular Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266000, China.
Peiyan WangInstitute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266021, China.
Yu WangInstitute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266021, China.
Yi JiaInstitute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266021, China.
Xiaopeng TangSchool of Basic Medicine, Qingdao University, Qingdao 266071, China.
Jianxun WangInstitute for Translational Medicine, the Affiliated Hospital of Qingdao University, Qingdao 266021, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Iron overload is strongly associated with heart disease. Ferroptosis is a new form of regulated cell death indicated in cardiac ischemia-reperfusion (I/R) injury. However, the specific molecular mechanism of myocardial injury caused by iron overload in the heart is still unclear, and the involvement of ferroptosis in iron overload-induced myocardial injury is not fully understood. In this study, we observed that ferroptosis participated in developing of iron overload and I/R-induced cardiomyopathy. Mechanistically, we discovered that Parkin inhibited iron overload-induced ferroptosis in cardiomyocytes by promoting the ubiquitination of long-chain acyl-CoA synthetase 4 (ACSL4), a crucial protein involved in ferroptosis-related lipid metabolism pathways. Additionally, we identified

Indexed as

ACSL4FerroptosisHeart diseasesI/RIron overloadMitochondrialp53Parkin

Identifiers

PMID40370554
PMCPMC12069115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.